Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hallucinations | 9 | 2024 | 366 | 2.220 |
Why?
|
Psychotic Disorders | 15 | 2024 | 3223 | 2.140 |
Why?
|
Schizophrenia | 20 | 2024 | 6937 | 1.340 |
Why?
|
Auditory Cortex | 3 | 2024 | 363 | 1.150 |
Why?
|
Delusions | 2 | 2013 | 298 | 0.690 |
Why?
|
Schizophrenic Psychology | 5 | 2017 | 1647 | 0.570 |
Why?
|
Bipolar Disorder | 10 | 2024 | 5091 | 0.510 |
Why?
|
Substance-Related Disorders | 3 | 2023 | 4419 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 14 | 2024 | 36430 | 0.400 |
Why?
|
Mental Health Services | 2 | 2020 | 1730 | 0.380 |
Why?
|
Psychomotor Performance | 2 | 2019 | 1879 | 0.370 |
Why?
|
Temporal Lobe | 3 | 2024 | 1695 | 0.320 |
Why?
|
Fructose | 1 | 2010 | 288 | 0.300 |
Why?
|
Cerebellum | 3 | 2021 | 1500 | 0.290 |
Why?
|
Public Health | 1 | 2020 | 2667 | 0.280 |
Why?
|
Ambulatory Care | 1 | 2015 | 2775 | 0.240 |
Why?
|
Neurofeedback | 1 | 2024 | 44 | 0.230 |
Why?
|
Psychoses, Substance-Induced | 1 | 2024 | 99 | 0.230 |
Why?
|
Mental Disorders | 2 | 2022 | 6839 | 0.220 |
Why?
|
Neuroprotective Agents | 1 | 2010 | 957 | 0.220 |
Why?
|
Brain Mapping | 5 | 2021 | 6626 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.200 |
Why?
|
Hospitals, Psychiatric | 1 | 2023 | 321 | 0.200 |
Why?
|
Somatosensory Disorders | 1 | 2022 | 49 | 0.200 |
Why?
|
Pandemics | 2 | 2021 | 8635 | 0.180 |
Why?
|
Memory | 3 | 2015 | 2187 | 0.160 |
Why?
|
Auditory Pathways | 1 | 2021 | 237 | 0.160 |
Why?
|
Frontal Lobe | 2 | 2016 | 1420 | 0.160 |
Why?
|
Adult | 24 | 2024 | 221122 | 0.150 |
Why?
|
Rest | 2 | 2015 | 919 | 0.150 |
Why?
|
Affective Disorders, Psychotic | 1 | 2019 | 186 | 0.150 |
Why?
|
Young Adult | 12 | 2024 | 59196 | 0.140 |
Why?
|
Amphetamine-Related Disorders | 2 | 2010 | 80 | 0.140 |
Why?
|
Humans | 35 | 2024 | 761326 | 0.130 |
Why?
|
Brain | 7 | 2021 | 27103 | 0.130 |
Why?
|
Medication Adherence | 2 | 2024 | 2176 | 0.120 |
Why?
|
Social Work | 1 | 2015 | 159 | 0.120 |
Why?
|
Neural Pathways | 3 | 2015 | 3057 | 0.120 |
Why?
|
Female | 22 | 2024 | 392485 | 0.110 |
Why?
|
Patient Dropouts | 1 | 2015 | 412 | 0.110 |
Why?
|
Azabicyclo Compounds | 1 | 2013 | 68 | 0.110 |
Why?
|
Social Adjustment | 1 | 2015 | 632 | 0.110 |
Why?
|
Child Abuse | 1 | 2022 | 1075 | 0.110 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12972 | 0.100 |
Why?
|
Prefrontal Cortex | 2 | 2015 | 2219 | 0.100 |
Why?
|
NAD | 1 | 2016 | 614 | 0.100 |
Why?
|
Functional Laterality | 2 | 2017 | 2256 | 0.100 |
Why?
|
Antipsychotic Agents | 2 | 2024 | 3067 | 0.100 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2012 | 98 | 0.100 |
Why?
|
Sleep Stages | 2 | 2013 | 693 | 0.090 |
Why?
|
Nerve Net | 2 | 2021 | 2288 | 0.090 |
Why?
|
Adolescent | 8 | 2024 | 88305 | 0.090 |
Why?
|
Male | 21 | 2024 | 360621 | 0.090 |
Why?
|
Suicide, Attempted | 1 | 2019 | 1398 | 0.090 |
Why?
|
Psychotherapy | 1 | 2019 | 1647 | 0.080 |
Why?
|
Face | 1 | 2016 | 1026 | 0.080 |
Why?
|
Neuropsychological Tests | 3 | 2019 | 7045 | 0.080 |
Why?
|
Myelin Sheath | 1 | 2013 | 653 | 0.080 |
Why?
|
Models, Neurological | 2 | 2022 | 1767 | 0.080 |
Why?
|
Polysomnography | 2 | 2013 | 1847 | 0.080 |
Why?
|
Piperazines | 2 | 2013 | 2519 | 0.070 |
Why?
|
Alcohol-Related Disorders | 1 | 2010 | 238 | 0.070 |
Why?
|
Hospitalization | 2 | 2024 | 10715 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5077 | 0.070 |
Why?
|
Cocaine-Related Disorders | 1 | 2010 | 461 | 0.070 |
Why?
|
Sleep | 2 | 2013 | 4765 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3768 | 0.070 |
Why?
|
Hypnotics and Sedatives | 1 | 2013 | 1178 | 0.060 |
Why?
|
Oxidative Stress | 1 | 2016 | 3108 | 0.060 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1988 | 0.060 |
Why?
|
Axons | 1 | 2013 | 1674 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 26108 | 0.060 |
Why?
|
Middle Aged | 7 | 2024 | 220774 | 0.060 |
Why?
|
Patient Care Team | 1 | 2015 | 2523 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20092 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2012 | 15835 | 0.060 |
Why?
|
Tobacco Use Disorder | 1 | 2010 | 703 | 0.060 |
Why?
|
Amphetamines | 1 | 2024 | 143 | 0.060 |
Why?
|
Tomography, Emission-Computed | 2 | 2004 | 1122 | 0.050 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2013 | 6019 | 0.050 |
Why?
|
Massachusetts | 1 | 2015 | 8837 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 1 | 2013 | 2399 | 0.050 |
Why?
|
Risperidone | 1 | 2024 | 381 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5334 | 0.050 |
Why?
|
Hippocampus | 1 | 2015 | 3763 | 0.050 |
Why?
|
Methamphetamine | 1 | 2004 | 165 | 0.050 |
Why?
|
Pindolol | 1 | 2001 | 34 | 0.050 |
Why?
|
Comorbidity | 1 | 2015 | 10498 | 0.050 |
Why?
|
Raphe Nuclei | 1 | 2001 | 103 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2024 | 1571 | 0.040 |
Why?
|
Methylphenidate | 1 | 2024 | 488 | 0.040 |
Why?
|
Receptors, Serotonin | 1 | 2001 | 208 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29588 | 0.040 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2004 | 625 | 0.040 |
Why?
|
Cerebral Cortex | 2 | 2012 | 5776 | 0.040 |
Why?
|
Psychopathology | 1 | 2022 | 431 | 0.040 |
Why?
|
Self Concept | 1 | 2024 | 1043 | 0.040 |
Why?
|
Conditioning, Classical | 1 | 2021 | 368 | 0.040 |
Why?
|
Catatonia | 1 | 2019 | 178 | 0.030 |
Why?
|
Central Nervous System Stimulants | 1 | 2024 | 1176 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2024 | 22124 | 0.030 |
Why?
|
Opioid-Related Disorders | 1 | 2010 | 2160 | 0.030 |
Why?
|
Employment | 1 | 2021 | 1118 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 849 | 0.030 |
Why?
|
Mood Disorders | 1 | 2001 | 1127 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2015 | 39108 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 74152 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2024 | 10764 | 0.030 |
Why?
|
Social Perception | 1 | 2016 | 433 | 0.020 |
Why?
|
Fear | 1 | 2021 | 1476 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2020 | 80575 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8632 | 0.020 |
Why?
|
Visual Perception | 1 | 2019 | 1385 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2016 | 2229 | 0.020 |
Why?
|
Blood Glucose | 1 | 2004 | 6389 | 0.020 |
Why?
|
Pyridines | 1 | 2001 | 2870 | 0.020 |
Why?
|
Anxiety | 1 | 2004 | 4571 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 2010 | 451 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2016 | 6231 | 0.020 |
Why?
|
Organ Size | 1 | 2012 | 2252 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7954 | 0.020 |
Why?
|
Depression | 1 | 2004 | 8122 | 0.010 |
Why?
|
Child | 2 | 2022 | 80156 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15719 | 0.010 |
Why?
|
Receptors, Serotonin, 5-HT1 | 1 | 2001 | 13 | 0.010 |
Why?
|
Receptors, Neurotransmitter | 1 | 2001 | 174 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2010 | 8997 | 0.010 |
Why?
|
Aged | 1 | 2013 | 169179 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12329 | 0.010 |
Why?
|
Child, Preschool | 1 | 2022 | 42251 | 0.010 |
Why?
|
Arousal | 1 | 2004 | 1166 | 0.010 |
Why?
|
Electroencephalography | 1 | 2013 | 6224 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4921 | 0.010 |
Why?
|
United States | 1 | 2024 | 72317 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2004 | 2009 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2001 | 1172 | 0.010 |
Why?
|
Attention | 1 | 2004 | 2395 | 0.010 |
Why?
|
Kinetics | 1 | 2001 | 6374 | 0.010 |
Why?
|
Image Enhancement | 1 | 2004 | 2884 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2004 | 2879 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2001 | 2897 | 0.000 |
Why?
|
Animals | 1 | 2021 | 168388 | 0.000 |
Why?
|
Cohort Studies | 1 | 2011 | 41440 | 0.000 |
Why?
|
Concepts
(144)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_